Table 3.

Mean Changes in Primary and Secondary Outcomes

Variable	Mean Change from Baseline (95% CI)		Between-Group Difference (95% CI)
	True Farabloc	Sham Farabloc	True vs. Sham	P Value
Phantom Limb Pain
Week 6	−1.4 (−6.4 to 3.6)	−2.2 (−6.2 to 1.8)	0.8 (−3.6 to 5.2)	0.78
Week 12	−2.2 (−6.4 to 2.0)	−2.4 (−6.8 to 2.0)	0.2 (-4.0 to 4.4)	0.38
Overall Pain
Week 6	−0.2 (−5.2 to 4.8)	−0.7 (−4.7 to 3.3)	0.5 (−4.1 to 5.1)	0.55
Week 12	−1.4 (−5.2 to 2.4)	−0.2 (−5.2 to 4.8)	−1.2 (−5.6 to 3.2)	0.22
PLP Frequency/wk
Week 6	−4.7 (−30.7 to 21.3)	−9.2 (−43.3 to 25.0)	4.5 (−25.7 to 34.7)	0.08
Week 12	−6.6 (−31.6 to 18.4)	−9.5 (−52.3 to 33.3)	2.9 (−31.1 to 36.9)	0.06
PLP Frequency/mo
Week 6	−24.8 (−139 to 89)	−39.9 (−74 to -5.7)	15.1 (−59.1 to 89.3)	0.10
Week 12	−31.7 (−165 to 102)	−40.1 (−211.9 to 131.7)	8.4 (−144.2 to 161)	0.09
VR-12 PCS
Week 6	0.6 (−10.0 to 11.2)	0.3 (−12.9 to 13.5)	0.3 (−9.5 to 10.1)	0.19
Week 12	0.3 (−9.7 to 10.3)	−0.2 (−13.2 to 12.8)	0.5 (−11.1 to 12.1)	0.14
VR-12 MCS
Week 6	−1.0 (−8.0 to 6.0)	1.6 (−13.0 to 16.2)	−2.6 (−13.4 to 8.2)	0.58
Week 12	−2.1 (−10.5 to 6.3)	1.8 (−14.0 to 17.6)	−3.9 (−16.1 to 8.3)	0.78